Literature DB >> 17451965

Immune status evaluation of patients with chronic heart failure.

Pavlos M Myrianthefs1, Nikolaos Lazaris, Kyriaki Venetsanou, Nikolaos Smigadis, Elias Karabatsos, Maria I Anastasiou-Nana, George J Baltopoulos.   

Abstract

Chronic heart failure (CHF) may be considered a state of immune activation and persistent inflammation expressed by increased circulating levels of pro- and anti-inflammatory cytokines. The purpose of the study was to investigate the immune status in patients with CHF compared to normal individuals. We measured serum cytokine levels as well as cytokine production after ex vivo LPS stimulation of whole blood taken from 14 patients with CHF and 14 healthy volunteers. We used 500 pg/ml of LPS for an incubation period of 4h to stimulate 100 microL of whole blood. Patients with CHF had significantly higher levels of TNF-RI, and TNF-RII in serum compared to normal individuals. TNF-alpha, IL-6, and IL-10 did not differ significantly. After LPS stimulation, patients with CHF had significantly higher levels of TNF-alpha and IL-10, and significantly lower IL-6 levels compared to normal individuals. TNF-alpha receptors did not differ significantly. Patients with CHF may be found in a pro- as well as an anti-inflammatory state. They also do not develop endotoxin tolerance in an ex vivo laboratory model using whole blood stimulated with LPS. They may have increased TNF-alpha and IL-10 production after LPS stimulation of whole blood, which may contribute to a worsening of heart function, more severe disease presentation and a worse outcome during infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451965     DOI: 10.1016/j.cyto.2007.03.007

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  An integrated microfluidic platform for in situ cellular cytokine secretion immunophenotyping.

Authors:  Nien-Tsu Huang; Weiqiang Chen; Bo-Ram Oh; Timothy T Cornell; Thomas P Shanley; Jianping Fu; Katsuo Kurabayashi
Journal:  Lab Chip       Date:  2012-10-21       Impact factor: 6.799

2.  Mao-to Prolongs the Survival of and Reduces TNF-alpha Expression in Mice with Viral Myocarditis.

Authors:  Zhu Shijie; Junji Moriya; Jun'ichi Yamakawa; Rui Chen; Takashi Takahashi; Hiroyuki Sumino; Takeshi Nakahashi; Kunimitsu Iwai; Shigeto Morimoto; Nobuo Yamaguchi; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-24       Impact factor: 2.629

3.  Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation.

Authors:  Yang Fan; Wu Weifeng; Yan Yuluan; Kong Qing; Pang Yu; Huang Yanlan
Journal:  Virol J       Date:  2011-01-14       Impact factor: 4.099

4.  Mycophenolic Acid Synergizing with Lipopolysaccharide to Induce Interleukin-1β Release via Activation of Caspase-1.

Authors:  Xue-Chan Huang; Yi He; Jian Zhuang; Juan He; Gui-Hu Luo; Jiao-Chan Han; Er-Wei Sun
Journal:  Chin Med J (Engl)       Date:  2018-07-05       Impact factor: 2.628

5.  Optimal method to stimulate cytokine production and its use in immunotoxicity assessment.

Authors:  Wenchao Ai; Haishan Li; Naining Song; Lei Li; Huiming Chen
Journal:  Int J Environ Res Public Health       Date:  2013-08-27       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.